AR

Akshay Rajkumar Jethliya

Active Director Director DIN 11265098
DIN 11265098 First appointment Aug 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Akshay Rajkumar Jethliya

Data last updated:

Akshay Rajkumar Jethliya is a Director at Jd Novagen Pharma Private Limited (since 2025).

DIN 11265098
Primary Designation Director
First Appointment 27 Aug 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Jd Novagen Pharma Private Limited U47721MH2025PTC455478
Director27 Aug 20252025Active

Board colleagues of Akshay Rajkumar Jethliya

NameDINCompanyDesignation
Siddhant Vijayrav Deshmukh11265097Jd Novagen Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Jd Novagen Pharma Private Limited
Premium access

Shareholding and investment profile for Akshay Rajkumar Jethliya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Akshay Rajkumar Jethliya

Akshay Rajkumar Jethliya currently holds 1 directorship: Jd Novagen Pharma Private Limited (Director, since 27 Aug 2025).

Akshay Rajkumar Jethliya was first appointed on 27 Aug 2025 as Director at Jd Novagen Pharma Private Limited.

The current boards of Akshay Rajkumar Jethliya's companies include Siddhant Vijayrav Deshmukh (Jd Novagen Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available